ATE255164T1 - Säugetier-rezeptoren für das melanocyten- stimulierendes hormon und deren verwendungen - Google Patents

Säugetier-rezeptoren für das melanocyten- stimulierendes hormon und deren verwendungen

Info

Publication number
ATE255164T1
ATE255164T1 AT93911605T AT93911605T ATE255164T1 AT E255164 T1 ATE255164 T1 AT E255164T1 AT 93911605 T AT93911605 T AT 93911605T AT 93911605 T AT93911605 T AT 93911605T AT E255164 T1 ATE255164 T1 AT E255164T1
Authority
AT
Austria
Prior art keywords
stimulating hormone
receptor
msh
melanocyte stimulating
cultures
Prior art date
Application number
AT93911605T
Other languages
English (en)
Inventor
Roger D Cone
Kathleen G Mountjoy
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Application granted granted Critical
Publication of ATE255164T1 publication Critical patent/ATE255164T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
AT93911605T 1992-04-10 1993-04-07 Säugetier-rezeptoren für das melanocyten- stimulierendes hormon und deren verwendungen ATE255164T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/866,979 US5532347A (en) 1992-04-10 1992-04-10 DNA encoding α melanocyte stimulating hormone receptor
PCT/US1993/003247 WO1993021316A1 (en) 1992-04-10 1993-04-07 Mammalian melanocyte stimulating hormone receptors and uses

Publications (1)

Publication Number Publication Date
ATE255164T1 true ATE255164T1 (de) 2003-12-15

Family

ID=25348840

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911605T ATE255164T1 (de) 1992-04-10 1993-04-07 Säugetier-rezeptoren für das melanocyten- stimulierendes hormon und deren verwendungen

Country Status (10)

Country Link
US (3) US5532347A (de)
EP (1) EP0635054B1 (de)
JP (1) JP3512797B2 (de)
AT (1) ATE255164T1 (de)
AU (1) AU686099B2 (de)
CA (1) CA2133843C (de)
DE (1) DE69333315T2 (de)
FI (1) FI944735L (de)
NO (1) NO316448B1 (de)
WO (1) WO1993021316A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6278038B1 (en) 1992-04-10 2001-08-21 Oregon Health And Science University Mammalian melanocortin receptors and uses
US5837521A (en) 1993-04-08 1998-11-17 State Of Oregon Nucleic acids encoding the γ-MSH receptor MC3-R
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
US5532347A (en) * 1992-04-10 1996-07-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization DNA encoding α melanocyte stimulating hormone receptor
WO1994004674A1 (en) * 1992-08-21 1994-03-03 Jarl Wikberg Human melanocyte stimulating hormone receptor
FR2713645A1 (fr) * 1993-12-08 1995-06-16 Inst Nat Sante Rech Med Polypeptides à activité de récepteur aux mélanocortines, médicaments les comprenant, séquences codant pour eux, sondes, vecteurs et hôtes les exprimant et application au criblage de médicaments.
US5622860A (en) * 1994-02-17 1997-04-22 The Regents Of The University Of Michigan Genes encoding melanocortin receptors
AU7959598A (en) * 1997-06-13 1998-12-30 Oregon Health Sciences University Mammalian melanocortin receptors and uses
US6645738B1 (en) 1998-11-09 2003-11-11 Merck & Co., Inc. DNA molecules encoding the melanocortin 5 receptor protein from rhesus monkey
EP1129105A4 (de) 1998-11-09 2005-03-30 Merck & Co Inc Dna moleküle, die den melancortin 4 rezeptor des rhesus-affen kodieren
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
JP2002533111A (ja) 1998-12-23 2002-10-08 メルク エンド カムパニー インコーポレーテッド ヒトメラノコルチン１受容体タンパク質のスプライス変化体をコードするｄｎａ分子
CN1429073A (zh) * 2000-04-28 2003-07-09 曾根公司 使用α－MSH及其衍生物的基因治疗系统和方法
US6593110B2 (en) * 2000-05-04 2003-07-15 California Institute Of Technology Checkpoint-activating oligonucleotides
FR2810883B1 (fr) 2000-06-28 2006-07-28 Seppic Sa Nouveaux latex inverses autoinversibles sur des esters d'acides gras, compositions cosmetiques, dermocosmetiques, dermopharmaceutiques ou pharmaceutiques en comportant
EP1322954A4 (de) * 2000-09-13 2005-08-03 Eleanor Roosevelt Inst Verfahren zur behandlung von insulinresistenz bei übergewichtigkeit und diabetes
US20030113263A1 (en) * 2001-02-13 2003-06-19 Oregon Health And Sciences University, A Non-Profit Organization Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia
AU2002318168B2 (en) 2002-02-25 2007-12-13 Vaxiion Therapeutics, Llc Minicell compositions and methods
FR2856691B1 (fr) 2003-06-26 2005-08-26 Seppic Sa Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant
FR2861397B1 (fr) 2003-10-22 2006-01-20 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse concentre, procede pour sa preparation et utilisation dans l'industrie
WO2005106484A1 (en) * 2004-04-30 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with melanocortin 1 receptor (mc1r)
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
FR2879607B1 (fr) 2004-12-16 2007-03-30 Seppic Sa Nouveaux latex inverse concentre, procede pour sa preparation, et utilisation dans l'industrie
US20080200408A1 (en) * 2005-09-30 2008-08-21 Mccormack Kenneth Deletion mutants of tetrodotoxin-resistant sodium channel alpha subunit
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
FR2950060B1 (fr) 2009-09-11 2011-10-28 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant
FR2959746B1 (fr) 2010-05-06 2012-06-15 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible, son utilisation comme agent epaississant dans une composition cosmetique
FR2992323B1 (fr) 2012-06-25 2015-07-03 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible exempt de tensioactif, son utilisation comme agent epaississant dans une composition cosmetique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650764A (en) * 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4861719A (en) * 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5532347A (en) 1992-04-10 1996-07-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization DNA encoding α melanocyte stimulating hormone receptor

Also Published As

Publication number Publication date
FI944735A7 (fi) 1994-12-02
EP0635054B1 (de) 2003-11-26
US6268221B1 (en) 2001-07-31
CA2133843A1 (en) 1993-10-11
EP0635054A1 (de) 1995-01-25
JPH07508643A (ja) 1995-09-28
AU4047793A (en) 1993-11-18
CA2133843C (en) 2003-02-11
WO1993021316A1 (en) 1993-10-28
NO943775D0 (no) 1994-10-07
JP3512797B2 (ja) 2004-03-31
FI944735L (fi) 1994-12-02
DE69333315T2 (de) 2004-09-30
NO943775L (no) 1994-12-01
DE69333315D1 (de) 2004-01-08
US5532347A (en) 1996-07-02
FI944735A0 (fi) 1994-10-07
US5849871A (en) 1998-12-15
NO316448B1 (no) 2004-01-26
AU686099B2 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
ATE255164T1 (de) Säugetier-rezeptoren für das melanocyten- stimulierendes hormon und deren verwendungen
Amsterdam et al. Coordinated regulation of morphological and biochemical differentiation in a steroidogenic cell: the granulosa cell model
UA84387C2 (ru) Человеческий цитокин как лиганд зальфа рецептора и его применение
DE69132447D1 (de) Menschlicher dopamin d4 rezeptor und seine verwendungen
ATE131871T1 (de) Rezeptoren für tumornekrosisfaktor-alpha und - beta
GR3020325T3 (en) Antibody antagonists of human interleukin-4
ES2095931T3 (es) Elementos de respuesta al acido retinoico beta, composiciones y pruebas.
Mensing et al. Enhanced chemotaxis of tumor‐derived and virus‐transformed cells to fibronectin and fibroblast‐conditioned medium
ATE203566T1 (de) Protein-g-gekoppelte glutaminsäure-rezeptoren
Rosemberg The Human Testis: Proceedings of the Workshop Conference Held at Positano, Italy, April 23–25, 1970
WO1994003602A3 (en) A novel human dopamine receptor and its uses
CA2133845A1 (en) Adrenocorticotrophic hormone receptor and uses
BR9913942A (pt) Polinucleotìdeo e polipeptìdeo isolado, vetor de expressão, célula cultivada, constructo de dna codificador de uma proteìna de fusão, processos de produção de uma proteìna, de fusão de um polipeptìdeo e de um anticorpo para o polipeptìdeo e de detecção, em uma amostra de teste, da presença de um modulador da atividade da proteìna zalpha11 e de um ligante de receptor zalpha11 dentro de uma amostra de teste, e, anticorpo
SE9201966D0 (sv) Interleukin-1beta deletion mutant
Niedziela et al. Direct effects of the pineal hormone melatonin on testosterone synthesis of Leydig cells in Djungarian hamsters (Phodopus sungorus) in vitro
Fan et al. Establishment and characterization of a novel untransfected corneal endothelial cell line from New Zealand white rabbits
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
GULIZIA et al. Evidence for the presence of androgen receptors in purified rat Leydig cells
Parivar DIFFERENTIATION OF SERTOLI CELLS AND POST—REPRODUCTIVE EPITHELIAL CELLS IN THE HERMAPHRODITE GLAND OF ARION ATER (L.)(MOLLUSCA, PULMONATA)
ATE123812T1 (de) Rezeptoren für granulozytenkolonien stimulierenden faktor.
Bordy et al. Active cell aggregation by immature rat Sertoli cells in primary culture: A role for cell surface glycoproteins
Hammond et al. Somatomedin (Sm) production by cultured porcine granulosa cells (GC)
Geradts et al. Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor
Tajima et al. Effects of hormones, cyclic AMP analogues and growth factors on steel factor (SF) production in mouse Sertoli cell cultures
Matsuo et al. Adrenocortical adenoma with primary aldosteronism in culture

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties